NCT04857632View on ClinicalTrials.gov

Statin for Neuroprotection in Spontaneous Intracerebral Hemorrhage

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

August 6, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

November 30, 2024

Conditions
Intracerebral HemorrhageStatins
Interventions
DRUG

Statin

atorvastatin 20mg per day for 7 days

Trial Locations (3)

100000

RECRUITING

Beijing Fengtai Youanmen Hospital, Beijing

100069

RECRUITING

Xuan Wu Hospital，Capital Medical University, Beijing

Unknown

RECRUITING

Hebei Province Shunping County Hospital, Baoding

All Listed Sponsors
lead

Capital Medical University

OTHER